| Authors: |
Hall A; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Croft J; The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital, London, UK., Walker K; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Boyd K; The Royal Marsden Hospital, London, UK., Roberts S; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Holroyd A; The Institute of Cancer Research, London, UK., Garg M; Leicester Royal Infirmary, Leicester, UK., Ferris E; The Institute of Cancer Research, London, UK., Cook G; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.; National Institute for Health and Care Research Leeds Biomedical Research Centre, Leeds, UK., Pierceall WE; Translational Development and Diagnostics, Celgene Corporation, Summit, New Jersey, USA., Thakurta A; Translational Development and Diagnostics, Celgene Corporation, Summit, New Jersey, USA., Gandhi A; Translational Development and Diagnostics, Celgene Corporation, Summit, New Jersey, USA., Pawlyn C; The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital, London, UK., Brown SR; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Kaiser M; The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital, London, UK. |